Protea Biosciences Group (PRGBQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,648 | -9,574 | -11,475 | -11,418 | -9,531 |
| Depreciation Amortization | 679 | 687 | 826 | 845 | 1,009 |
| Accounts receivable | -260 | 78 | -60 | -93 | -81 |
| Accounts payable and accrued liabilities | 458 | 149 | 811 | -1,990 | -233 |
| Other Working Capital | 461 | 109 | 1,667 | -1,740 | -429 |
| Other Operating Activity | 10,082 | 2,988 | 898 | 4,175 | 744 |
| Operating Cash Flow | $-4,228 | $-5,565 | $-7,333 | $-10,221 | $-8,522 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | 124 | -408 | -478 | -408 |
| Net Acquisitions | N/A | N/A | 524 | N/A | N/A |
| Sale Of Investment | 1,502 | 910 | N/A | N/A | N/A |
| Other Investing Activity | 46 | 0 | 0 | 0 | 50 |
| Investing Cash Flow | $1,479 | $1,034 | $116 | $-478 | $-358 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,513 | 3,403 | 4,406 | 3,595 | 2,963 |
| Debt Issued | N/A | 200 | N/A | N/A | N/A |
| Debt Repayment | -1,339 | -652 | -1,150 | -858 | -278 |
| Common Stock Issued | 1,108 | 1,112 | 14 | 9,353 | 5,739 |
| Other Financing Activity | -461 | 151 | 3,205 | -361 | 0 |
| Financing Cash Flow | $2,822 | $4,213 | $6,475 | $11,728 | $8,424 |
| Exchange Rate Effect | 0 | 0 | -21 | 30 | -21 |
| Beginning Cash Position | 7 | 323 | 1,086 | 28 | 505 |
| End Cash Position | 79 | 7 | 323 | 1,086 | 28 |
| Net Cash Flow | $72 | $-316 | $-764 | $1,059 | $-478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,228 | -5,565 | -7,333 | -10,221 | -8,522 |
| Capital Expenditure | -120 | -119 | -414 | -479 | -408 |
| Free Cash Flow | -4,349 | -5,684 | -7,747 | -10,700 | -8,930 |